| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
|
| | FI | PI | | Burgerstein Vitamin C retard | 30 | PA | PA | k.A. | | Kapseln: Acidum Ascorbicum 500 mg | Antistress Aktiengesellschaft für Gesundheitsschutz | D | FB | | G |  |
| | FI | PI | | Burgerstein Vitamin C retard | 100 | PA | PA | k.A. | | Kapseln: Acidum Ascorbicum 500 mg | Antistress Aktiengesellschaft für Gesundheitsschutz | D | FB | | G |  |
| | FI | PI | | Redoxon orange 1g | 30 Tablette(n) | PA | PA | k.A. | | Brausetabletten: Acidum Ascorbicum 1 g | Bayer (Schweiz) AG | D | FB | | G |  |
| | FI | PI | | Redoxon Orangenaroma | 60 Tablette(n) | PA | PA | k.A. | | : Acidum Ascorbicum 500 mg | Bayer (Schweiz) AG | D | FB | | G |  |
| | FI | PI | | Cegrovit | 10 | PA | 6.50 | k.A. | | Brausetabletten: Acidum Ascorbicum 1 g | HELP Pharma Switzerland AG | D | FB | | G |  |
| | FI | | | Vitamin C Streuli 10 %/ 5 mL | 10 Ampulle(n) | PA | PA | k.A. | | Injektionslösung: Acidum Ascorbicum 500mg / 5ml | Streuli Pharma AG | B | FB | | G |  |
| | FI | | | Vitamin C Streuli 20 %/ 5 mL | 10 Ampulle(n) | PA | PA | k.A. | | Injektionslösung: Acidum Ascorbicum 1000mg / 5ml | Streuli Pharma AG | B | FB | | G |  |
| | | | | Actilife Vitamin C 150 mg Acerola | 20 Brausetabletten | PA | PA | k.A. | | Brausetabletten: 2 Wirkstoffe | Migros- Genossenschafts-Bund | E | FB | | G |  |
| | | | | Actilife Vitamin C 150 mg Acerola | 20 Brausetabletten | PA | PA | k.A. | | Brausetabletten: 2 Wirkstoffe | Migros- Genossenschafts-Bund | E | FB | | G |  |
| | | | | Actilife Vitamin C 150 mg Acerola | 20 Brausetabletten | PA | PA | k.A. | | Brausetabletten: 2 Wirkstoffe | Migros- Genossenschafts-Bund | E | FB | | G |  |
| | | | | C-Naryl | 90 Tablette(n) | PA | 16.00 | k.A. | | Tabletten: Acidum Ascorbicum 500 mg | Laboratoire Dr. E. Homberger SA | D | FB | | G |  |
| | | | | Taxofit Vitamin C | 20 Kautabletten | PA | PA | k.A. | | Kautabletten: Acidum Ascorbicum 500 mg | Melisana AG | D | FB | | G |  |
| | | | | Taxofit Vitamin C | 20 Brausetabletten | PA | PA | k.A. | | Brausetabletten: Acidum Ascorbicum 500 mg | Melisana AG | D | FB | | G |  |
| | | PI | | Vicemex | 10 Brausetabletten | PA | PA | k.A. | | Brausetabletten: Acidum Ascorbicum 1 g | Acino Pharma AG | D | FB | | G |  |
| | | PI | | Viforcit | 10 Brausetabletten | PA | PA | k.A. | | Brausetabletten: Acidum Ascorbicum 1 g | Vifor (International) AG | D | FB | | G |  |
| | | | | Vitamin C UPSA | 30 Kautabletten | PA | PA | k.A. | | Kautabletten: 2 Wirkstoffe | Upsamedica GmbH | D | FB | | G |  |
| | | | | Vitamin C UPSA | 30 Kautabletten | PA | PA | k.A. | | Kautabletten: 2 Wirkstoffe | Upsamedica GmbH | D | FB | | G |  |
|
L | | FI | | I/B | Infanrix DTPa-IPV | | 20.20 | 38.40 | 10% | | 8 Wirkstoffe | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Arnuity Ellipta 90 mcg | 30 Einzeldosen | 15.60 | 33.40 | 10% | | : Fluticasoni Furoas 90 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Arnuity Ellipta 90 mcg | 3 x 30 | 46.80 | 67.30 | 10% | | : Fluticasoni Furoas 90 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
L | | FI | | PS | Herceptin subkutan 600mg/5ml | | 1484.04 | 1630.40 | 10% | | : Trastuzumabum 600mg / 5ml | Roche Pharma (Schweiz) AG | A / SL | FB | | G |  |
| | FI | PI | | Incruse Ellipta | 30 Einzeldosen | 34.64 | 54.10 | 10% | | Inhalationspulver: Umeclidinium 62.5 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | FI | PI | | Incruse Ellipta | 3 x 30 Einzeldosen | 103.00 | 128.45 | 10% | | Inhalationspulver: Umeclidinium 62.5 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
L | | FI | PI | | Microlax | 4 x 5 ml | 4.15 | 7.65 | 10% | | Klistier: 3 Wirkstoffe | JNTL Consumer Health II (Switzerland) GmbH | D / SL | FB | | G |  |
L | | FI | PI | | Microlax | 12 x 5 ml | 12.45 | 23.00 | 10% | | Klistier: 3 Wirkstoffe | JNTL Consumer Health II (Switzerland) GmbH | D / SL / LPPV | FB | | G |  |
L | | FI | PI | | Microlax | 50 x 5 ml | 51.88 | 95.80 | 10% | | Klistier: 3 Wirkstoffe | JNTL Consumer Health II (Switzerland) GmbH | D / SL / LPPV | FB | | G |  |
L | | FI | | | Ogivri 150 mg | | 456.84 | 513.25 | 10% | | : Trastuzumabum 150 mg | Medius AG | A / SL | FB | | G |  |
L | | FI | | | Vegzelma 100 mg/4 ml | | 257.57 | 296.55 | 10% | | Infusionskonzentrat: Bevacizumabum 100mg / 4ml | iQone Healthcare Switzerland SA | A / SL | FB | | G |  |
L | | FI | | | Vegzelma 400 mg/16 ml | | 962.84 | 1063.55 | 10% | | Infusionskonzentrat: Bevacizumabum 400mg / 16ml | iQone Healthcare Switzerland SA | A / SL | FB | | G |  |
L | | FI | PI | | Vitamin D3 Sandoz eco 3200 I.E. | 30 | 5.38 | 15.10 | 10% | | Weichkapseln: Cholecalciferolum 3200 UI | Sandoz Pharmaceuticals AG | ● B / SL | FB | | G |  |
L | | FI | PI | | Vitamin D3 Sandoz eco 3200 I.E. | 90 | 16.13 | 33.95 | 10% | | Weichkapseln: Cholecalciferolum 3200 UI | Sandoz Pharmaceuticals AG | ● B / SL | FB | | G |  |
| | FI | PI | | Casgevy 4-13 x 10e6 cells/ml | | PA | PA | k.A. | | | Vertex Pharmaceuticals (CH) GmbH | A | FB | | G |  |
| | FI | PI | | BILAXIN Ophta 6 mg / ml | 5 ml | PA | PA | k.A. | | Augentropfen: Bilastinum 6 mg/ml | A. Menarini GmbH | D | FB | | G |  |
| | FI | | | Mylotarg 5 mg | | PA | PA | k.A. | | : Gemtuzumabum Ozogamicinum 5 mg | Pfizer AG | A | FB | | G |  |
| | FI | PI | | Nicorette Microtab Original-Aroma | 100 Tablette(n) | PA | PA | k.A. | | Sublingualtabletten: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Regaine 5 % | 60 ml | PA | PA | k.A. | | Lösung: Minoxidilum 50 mg/ml | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Regaine 5 % | 3 x 60 ml | PA | PA | k.A. | | Lösung: Minoxidilum 50 mg/ml | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | | | Arnuity Ellipta 46 mcg | 30 | PA | PA | k.A. | | : Fluticasoni Furoas 46 µg | GlaxoSmithKline AG | B | FB | | G |  |